Disc susceptibility testing for thermophilic campylobacters

Pathology

Volumn 29, Issue 2, 1997, Pages 209-216

  Huysmans, Michael B ^a   Turnidge, John D ^a  

^a MONASH MEDICAL CENTRE   (Australia)

Author keywords

Antibiotic resistance; Campylobacter; Microbial sensitivity tests

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFALOTIN; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; NALIDIXIC ACID; NORFLOXACIN; PIPERACILLIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CAMPYLOBACTER; CAMPYLOBACTER JEJUNI; CONTROLLED STUDY; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STRAIN DIFFERENCE; THERMOPHILIC BACTERIUM;

EID: 0030871971     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/00313029700169884     Document Type: Article

References (38)

1. Blaser MJ. Campylobacter and related species. In: Mandell GL, Bennett JE, Dolin R editors Principles and practice of infectious diseases, 4th ed. New York: Churchill Livingston, 1995; 1948-56.
2. Skirrow MB. Campylobacter enteritis: the first five years. J Hyg 1982; 89: 175.
3. Adler-Mosca H, Lüthy-Hottenstein J, Martinetti Luchini G, Burnens A, Altwegg M. Development of resistance to quinolones in five patients with campylobacteriosis treated with norfloxacin or ciprofloxacin. Eur J Clin Microbiol Infect Dis 1991; 10: 953-7.
4. Goodman LJ, Trenholme GM, Kaplan RL, Segreti J, Hines D, Petrak R, Nelson JA, Mayer KW, Landau W, Parkhurst GW, Levin S. Empiric antimicrobial therapy of domestically acquired acute diarrhoea in urban adults. Arch Int Med 1990; 150: 541-6.
5. Kuschner RA, Trofa AF, Thomas RJ, Hoge CW, Pitarangsi C, Amato S, Olafson RP, Echeverria P, Sadoff JC, Taylor DN. Use of azithromycin for the treatment of campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent. Clin Infect Dis 1995; 21: 536-41.
6. Petruccelli BP, Murphy GS, Sanchez JL, Walz S, DeFraites R, Gelnett J, Haberberger RL, Echeverria P, Taylor DN. Treatment of traveler's diarrhea with ciprofloxacin and loperamide. J Infect Dis 1992; 165: 557-60.
7. Tee W, Mijch A, Wright E, Yung A. Emergence of multidrug resistance in Campylobacter jejuni isolates from three patients infected with Human Immunodeficiency Virus. Clin Infect Dis 1995; 21: 634-8.
8. Wiström J, Jertborn M, Ekwall E, Norlin K, Söderquist B, Strömberg A, Lundholm R, Hogevik H, Lagergren L, Englund G, Norrby SR and the Swedish Study Group. Empiric treatment of acute diarrhoeal disease with norfloxacin. A randomised, placebo-controlled trial. Ann Int Med 1992; 117: 202-8.
9. Bowler I, Day D. Emerging quinolone resistance in campylobacters. Lancet 1992; 340: 245 (Letter).
10. Chatzipanagiotou S, Papavasiliou E, Malamou-Lada E. Isolation of Campylobacter jejuni strains resistant to nalidixic acid and fluoroquinolones from children with diarrhea in Athens, Greece. Eur J Clin Microbiol Infect Dis 1993; 12: 566-8.
11. Rautelin H, Renkonen O-V, Kosunen TU. Emergence of fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli in subjects from Finland. Antimicrob Agents Chemother 1991; 35: 2065-9.
12. Sjögren E, Kaijser B, Werner M. Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli isolated in Sweden: a 10-year follow-up report. Antimicrob Agents Chemother 1992; 36: 2847-9.
13. Taylor DN, Blaser M, Echeverria P, Pitarangsi C, Bodhidatta L, Wang W-LL. Erythromycin-resistant Campylobacter infections in Thailand. Antimicrob Agents Chemother 1987; 31: 438-42.
14. Winstanley TG, Rice PS, Spencer RC. Multiple antibiotic resistance in a strain of Campylobacter jejuni acquired in Jordan. J Antimicrob Chemother 1993; 31: 178-9 (Letter).
15. Endtz HP, Ruijs GJ, van Klingeren B, Jansen WH, van der Reyden T, Mouton RP. Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. J Antimicrob Chemother 1991; 27: 199-208.
16. Nachamkin I. Campylobacter and Arcobacter. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH ed. Manual of clinical microbiology, 6th ed. Washington D.C.: American Society for Microbiology, 1995; 483-91.
17. Huysmans M, Turnidge J, Williams J. Evaluation of API Campy in comparison with conventional methods for identification of thermophilic campylobacters. J Clin Microbiol 1995; 33: 3345-6.
18. Ferguson DA Jr, Lambe DW Jr. Differentiation of Campylobacter species by protein banding patterns in polyacrylamide slab gels. J Clin Microbiol 1984; 20: 453-60.
19. Tee W, Anderson BN, Ross BC, Dwyer B. Atypical campylobacters associated with gastroenteritis. J Clin Microbiol 1987; 25: 1248-52.
20. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically - 3rd ed. Approved standard. NCCLS document M7-A3. NCCLS, Villanova, Pa.; 1993.
21. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disc susceptibility tests - 5th ed. Approved standard. NCCLS document M2-A5. NCCLS, Villanova, Pa.; 1993.
22. Metzler CM, DeHaan RM. Susceptibility tests of anaerobic bacteria: statistical and clinical considerations. J Infect Dis 1974; 130: 588-94.
23. National Committee for Clinical Laboratory Standards. Development of in vitro susceptibility testing criteria and quality control parameters. Approved guideline. NCCLS document M23-A. NCCLS, Villanova, Pa.; 1994.
24. Michel J, Rogol M, Dickman D. Susceptibility of clinical isolates of Campylobacter jejuni to sixteen antimicrobial agents. Antimicrob Agents Chemother 1983; 23: 796-7.
25. Secker DA. Erythromycin resistance found only in Campylobacter coli. J Antimicrob Chemother 1983; 12: 414-5 (Letter).
26. Svedhcm Å, Kaijser B, Sjögren E. Antimicrobial susceptibility of Campylobacter jejuni isolated from humans with diarrhoea and from healthy chickens. J Antimicrob Chemother 1981. 7: 301-5.
27. Wang W-LL, Relier LB, Blaser MJ. Comparison of antimicrobial susceptibility patterns of Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother 1984; 26: 351-3.
28. Elharrif Z, Mégraud F, Marchand A-M. Susceptibility of Campylobacter jejuni and Campylobacter coli to macrolides and related compounds. Antimicrob Agents Chemother 1985; 28: 695-7.
29. Fliegelman RM, Petrak RM, Goodman LJ, Segreti J, Trenholme GM, Kaplan RL. Comparative in vitro activities of twelve antimicrobial agents against Campylobacter species. Antimicrob Agents Chemother 1985; 27: 429-30.
30. Barrett JE, Kaplan RL, Goodman LJ. Campylobacter: a method for routine antimicrobial susceptibility testing. In: Proceedings of the Second International Workshop on Campylobacter Infections. London: Public Health Laboratory Service, 1983; abstr. p. 26-7.
31. Vanhoof R, Dierickx R, Coignau H, Hubrechts JMH, Kaufman L, Butzler JP. Disc sensitivity testing for Campylobacter jejuni. Eur J Clin Microbiol 1984; 3: 160-2.
32. Vanhoof R, Vanderlindern MP, Dierickx R, Lauwers S, Yourassowsky E, Butzler JP. Susceptibility of Campylobacter fetus subsp. jejuni to twenty-nine antimicrobial agents. Antimicrob Agents Chemother 1978; 14: 553-6.
33. Ng L-K, Stiles ME, Taylor DE. Inhibition of Campylobacter coli and Campylobacter jejuni by antibiotics used in selective growth medium. J Clin Microbiol 1985, 22: 510-4.
34. Ng L-K, Taylor DE, Stiles ME. Characterisation of freshly isolated Campylobacter coli strains and suitability of selective media for their growth. J Clin Microbiol 1988; 26: 518-23.
35. Altwegg M, Burnens A, Zollinger-Iten J, Penner JL. Problems in identification of Campylobacter jejuni associated with acquisition of resistance to nalidixic acid. J Clin Microbiol 1987; 25: 1807-8.
36. Figueroa G, Troncoso M, Galeno H, Soto V, Toledo MS. Biotypes, serogroups and antibiotic susceptibility of Campylobacter jejuni and Campylobacter coli in Chile. J Infect 1990; 20: 123-7.
37. Sagara H, Mochizuki A, Okamura N, Nakaya R. Antimicrobial resistance of Campylobacter jejuni and Campylobacter coli with special reference to plasmid profiles of Japanese clinical isolates. Antimicrob Agents Chemother 1987; 32: 713-9.
38. Shanker S, Sorrell TC. Susceptibility of Campylobacter jejuni to twenty-three antimicrobial agents. Pathology 1983; 15: 61-3.